Company page

Relay Therapeutics, Inc.

Relay Therapeutics, Inc. is a public company traded under the ticker RLAY in the American market. With a market capitalization of approximately $3.46 billion, the company focuses on advancing its innovative approach to drug discovery and development. Relay Therapeutics aims to transform the treatment of diseases through its proprietary technology platform.